Search results for "Infectious Diseases"


 
Results 71 - 80 of about 301 for "Infectious Diseases".
Sort by: Relevance | Newest | Oldest

Antibiotic stewardship improved prescribing for suspected UTI in frail older adults

Inappropriate antibiotic prescribing for suspected urinary tract infections (UTIs) was reduced in practices and facilities assigned to use a decision tool instead of usual care, particularly for patients with dementia, a randomized trial in Europe found.
https://immattersacp.org/weekly/archives/2023/02/28/5.htm
28 Feb 2023

Guidelines suggest fidaxomicin over vancomycin for Clostridioides difficile infection

The Infectious Diseases Society of America and Society for Healthcare Epidemiology of America made three new recommendations in a focused update of their guidelines on Clostridioides difficile infection.
https://immattersacp.org/weekly/archives/2021/06/29/5.htm
29 Jun 2021

Obituaries

The College notes the passing of Michael F. Rein, MD, MACP; William R. Smith, MD, MACP; Cyril (Kim) M. Hetsko, MD, MACP; and Alan Gordon, MD, MACP.
https://immattersacp.org/archives/2023/01/obituaries.htm
1 Jan 2023

CDC issues interim guidance on evaluation, treatment of suspected vaping injuries

The evaluation of patients with suspected e-cigarette, or vaping, product use-associated lung injury (EVALI) should include pulse oximetry, chest X-ray, and, in some cases, chest CT, the CDC advised.
https://immattersacp.org/weekly/archives/2019/10/22/2.htm
22 Oct 2019

Prepare for next pandemic by training leaders

In response to the COVID-19 pandemic and the prospect of others, public health and medical groups are developing training initiatives to increase the numbers of infectious disease and public health specialists across the country.
https://immattersacp.org/archives/2023/03/prepare-for-next-pandemic-by-training-leaders.htm
1 Mar 2023

Latest COVID-19 guidelines come out against bamlanivimab, remdesivir

The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020

Latest research looks at prolonged symptoms, drug treatments in COVID-19

Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021

ACP, Annals of Internal Medicine host ‘Monkeypox: Challenging Clinical Questions’

The virtual forum featured a panel of physicians providing answers to commonly asked questions about the human monkeypox virus and is available for replay online.
https://immattersacp.org/weekly/archives/2022/10/18/5.htm
18 Oct 2022

New reports on early symptoms, cardiac complications of COVID-19

Loss of smell and taste have been suggested as possible early symptoms of COVID-19, and cardiac complications appear to be a significant issue among infected patients with or without baseline cardiovascular disease.
https://immattersacp.org/weekly/archives/2020/03/31/2.htm
31 Mar 2020

ATS/IDSA release clinical practice guideline on diagnosing, treating CAP

The new American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) guideline updates the 2007 community-acquired pneumonia (CAP) guideline, and changes include a different perspective on macrolides.
https://immattersacp.org/weekly/archives/2019/10/08/4.htm
8 Oct 2019

Result Page: Prev   3   4   5   6   7   8   9   10   11   12   Next